DW 286

Drug Profile

DW 286

Alternative Names: DW 286a; DW286

Latest Information Update: 01 Sep 2010

Price : $50

At a glance

  • Originator Dong Wha
  • Developer Dong Wha Pharmaceutical
  • Class Antibacterials; Naphthyridines
  • Mechanism of Action Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Bacterial infections

Most Recent Events

  • 01 Sep 2010 Discontinued - Phase-I for Bacterial infections in South Korea (PO)
  • 16 Feb 2006 Phase-I clinical trials in Bacterial infections in South Korea (PO)
  • 06 Jul 2005 This compound is still in active development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top